Shedding of mutant tumor necrosis factor receptor superfamily 1A associated with tumor necrosis factor receptor–associated periodic syndrome: Differences between cell types
Open Access
- 5 August 2004
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 50 (8) , 2651-2659
- https://doi.org/10.1002/art.20380
Abstract
Objective To investigate the effect of mutations in tumor necrosis factor receptor superfamily 1A (TNFRSF1A) on the ability of the receptors to be cleaved from the cell surface upon stimulation. The mutations we studied are associated with clinically distinct forms of TNF receptor–associated periodic syndrome (TRAPS). We also investigated different cell types within the same form of TRAPS. Methods The shedding of TNFRSF1A in response to stimulation with phorbol myristate acetate was assessed in leukocytes and dermal fibroblasts from patients with C33Y TRAPS, and in HEK 293 cell lines stably transfected with constructs containing wild‐type TNFRSF1A and/or TNFRSF1A mutants identified in TRAPS patients. Results The shedding of TNFRSF1A differed between cell types within the same form of TRAPS. In particular, dermal fibroblasts, but not leukocytes, from C33Y TRAPS patients demonstrated reduced shedding of TNFRSF1A. Shedding of both wild‐type and mutant TNFRSF1A from the transfected HEK 293 cells showed minor differences, but was in all cases induced to a substantial extent. Conclusion Differences in TNFRSF1A shedding are not purely a function of the TNFRSF1A structure, but are also influenced by other features of genetic makeup and/or cellular differentiation. It is unlikely that a defect in TNFRSF1A shedding per se can fully explain the clinical features that are common to TRAPS patients with different TNFRSF1A mutations.Keywords
This publication has 23 references indexed in Scilit:
- Heterogeneity among patients with tumor necrosis factor receptor–associated periodic syndrome phenotypesArthritis & Rheumatism, 2003
- Tumor necrosis factor receptor-associated periodic syndrome characterized by a mutation affecting the cleavage site of the receptor: Implications for pathogenesisArthritis & Rheumatism, 2003
- The TNF Receptor-Associated Periodic Syndrome (TRAPS)Medicine, 2002
- Identification of ARTS-1 as a novel TNFR1-binding protein that promotes TNFR1 ectodomain sheddingJournal of Clinical Investigation, 2002
- The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor–associated periodic syndromeArthritis & Rheumatism, 2002
- A novel mutation in the third extracellular domain of the tumor necrosis factor receptor 1 in a Finnish family with autosomal‐dominant recurrent feverArthritis & Rheumatism, 2002
- Differential activation of nuclear factor‐κB by tumour necrosis factor receptor subtypes. TNFR1 predominates whereas TNFR2 activates transcription poorlyFEBS Letters, 2002
- The Tumor-Necrosis-Factor Receptor–Associated Periodic Syndrome: New Mutations in TNFRSF1A, Ancestral Origins, Genotype-Phenotype Studies, and Evidence for Further Genetic Heterogeneity of Periodic FeversAmerican Journal of Human Genetics, 2001
- Autosomal-dominant periodic fever with AA amyloidosis: Novel mutation in tumor necrosis factor receptor 1 gene Rapid CommunicationKidney International, 2001
- Clinical Spectrum of Familial Hibernian Fever: A 14-Year Follow-Up Study of the Index Case and Extended FamilyMayo Clinic Proceedings, 1997